The researchers developed a redox-activated liposome called IND@RAL (Figure 17A), which could induce ICD and reverse the tumor suppressor microenvironment simultaneously by porphyrin-phospholipid coupling self-assembly and remote loading of IDO inhibitors (NLG8189) in the cavity. Here, IDO1 is linked to neoplasm.